Jun Kwan a, *, Marc A. Gillinov c, James D. Thomas b, Takahiro Shiota b

Size: px
Start display at page:

Download "Jun Kwan a, *, Marc A. Gillinov c, James D. Thomas b, Takahiro Shiota b"

Transcription

1 Eur J Echocardiography (2007) 8, 195e203 Geometric predictor of significant mitral regurgitation in patients with severe ischemic cardiomyopathy, undergoing Dor procedure: A real-time 3D echocardiographic study Jun Kwan a, *, Marc A. Gillinov c, James D. Thomas b, Takahiro Shiota b a Department of Cardiology, Inha University Hospital, 7-206, 3-Ga, Shinheung-Dong, Jung-Gu, Inchon , Republic of Korea b Cardiovascular Imaging Center, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA c Department of Cardiac Surgery, The Cleveland Clinic Foundation, Cleveland, OH, USA Received 24 November 2005; received in revised form 26 February 2006; accepted 2 March 2006 Available online 18 April 2006 KEYWORDS Cardiomyopathy; Mitral valve; Echocardiography Abstract Background and purpose: Significant mitral regurgitation (MR) is frequently associated with coronary artery disease. The precise geometric predictors of significant MR in ischemic cardiomyopathy are not clearly defined. We performed real-time 3D echocardiography (RT3DE) in 48 patients scheduled for infarct exclusion surgery or Dor procedure, 22 of whom had moderate or severe MR (DorMR) and 26 with no or trivial MR (DorNoMR). Methods: Two orthogonal apical volumetric planes of LV, commissureecommissure (CC) and antero-posterior (AP) planes, were generated during mid-systole. Mitral valve tenting height (MVTht) and area (MVTa) were measured. The degree of leaflet tethering was estimated by the angles between the annular plane and each leaflet (anterior leaflet: Aa, posterior leaflet: Pa). Results: MVTht ( vs cm, P < 0.01) and MVTa ( vs cm 2, P < 0.01) were significantly larger in DorMR compared with Dor- NoMR. In DorMR, both Aa (38 6vs317, P < 0.01) and Pa (60 7vs418, P < 0.01) significantly increased more than those in DorNoMR. Multiple logistic regression analysis found Pa to be the most important geometric predictor of significant MR. MV tenting area was found to be the strongest determinant of MR severity in ischemic cardiomyopathy patients with significant MR by multivariate linear regression analysis. * Corresponding author. Tel.: þ ; fax: þ address: kuonmd@inha.ac.kr (J. Kwan) /$32 ª 2006 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved. doi: /j.euje

2 196 J. Kwan et al. Conclusions: Detecting significant posterior leaflet tethering, the most important predictor of significant MR, and measuring MV tenting area, the strongest determinant of MR severity, using RT3DE may be helpful in decision making of additive surgical intervention for MR in patients with severe ischemic cardiomyopathy. ª 2006 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved. Ischemic mitral regurgitation (MR) is functional MR caused by coronary artery disease, in particular, right and left circumflex artery disease. 1 The prognostic implication of ischemic MR in the chronic phase is associated with excess mortality independent of baseline characteristics and degree of ventricular function. 2 The precise geometric determinants of ischemic MR have not been clearly understood, although such knowledge is important to improve mitral valve reparative techniques. Advances in three-dimensional (3D) echocardiography have provided much additional information on geometry of the mitral apparatus and allowed us to understand the mechanism for ischemic MR. 3e5 Real-time three-dimensional echocardiography (RT3DE) has been validated for its quantitative accuracy of geometric measurement of cardiac structure as well as volume measurement. 6e8 The purpose of this study was to determine the geometric predictors of significant MR and to investigate determinants of MR severity in the patients with severe ischemic cardiomyopathy using RT3DE. Methods We studied 48 patients with severe ischemic cardiomyopathy scheduled for infarct exclusion surgery, so called Dor procedure, 22 of whom had significant MR (moderate or severe MR from the color flow mapping) (DorMR) and 26 patients with no or trivial MR (DorNoMR). Inclusion criteria were (1) structurally normal mitral valve; (2) available color flow and Doppler image allowing calculating regurgitant orifice area (ROA); (3) available RT3DE image of LV chamber and the mitral apparatus allowing analysis of 3D geometry; and (4) sinus rhythm. Exclusion criteria were (1) clinical and echocardiographic evidences of other cardiac disease, such as organic valvular or infiltrative heart disease; (2) organic abnormality of the mitral apparatus such as chordae rupture, mitral valve prolapse or restricted leaflet due to degenerative calcification; (3) suboptimal 2D or 3D echocardiographic image leading to incomplete quantification of ROA or incomplete analysis of 3D geometry of the LV chamber and the mitral apparatus; and (4) atrial fibrillation. 2D echocardiographic measurements 2D echocardiography was performed with a phased array ultrasound sector scanner of a Sequoia 512 (Acuson) using a multifrequency 3.5e5 MHz probe. Posterior wall motion was estimated by semiquantitative grade as 1 for normal, 2 for mild to moderate hypokinesia, 3 for severe hypokinesia, 4 for akinesia, 5 for dyskinesia on a parasternal short axis view and multiple apical imaging planes. Wall motion with grade >3 was defined as significant wall motion abnormality. LV end diastolic volume (EDV) and end systolic volume (ESV) and ejection fraction (EF) were measured by the biplane Simpson disk method. 9 In DorMR group (significant MR from the color flow mapping), MR severity was quantified by ROA (cm 2 ) using the simple proximal isovelocity surface area (PISA) method. 10 Real-time 3D echocardiography Volumetric image acquisition An RT3DE imaging system with a 2.5 MHz hand held transducer was used to image the mitral apparatus (Volumetric Medical Imaging Inc., Durham, North Carolina). For all patients, transthoracic volumetric images were obtained using the apical view. Care was taken to include the entire mitral apparatus in the volumetric data set during one cardiac cycle. The volumetric frame rate was 17e22 volumes/s with an imaging depth of 12e16 cm. All volumetric images were digitally stored on magneto-optical disk and transferred into a personal computer for off-line analysis. 3D echocardiographic measurements We used a 3D computer software (TomTec, Inc., Munich, Germany), to define exact planes. First, a mid-systole of heart cycle was defined. Then, a cross-sectional plane of the mitral valve that clearly visualized both mitral commissures was used to define the commissureecommissure (CC)

3 Geometric predictor of ischemic mitral regurgitation 197 Figure 1 Volumetric images showing how to obtain 2 longitudinal apical planes using TomTec 3D software. By rotating the longitudinal plane on cross-sectional volumetric image at MV level (bottom left), CC plane (top right) connecting both commissures and AP plane (top left, bottom right) were obtained. Geometric measurements of the mitral valve were measured on these 2 longitudinal planes. AML, anterior mitral leaflet; PML, posterior mitral leaflet; MVTht, mitral valve tenting height; MVTa, mitral valve tenting area; Aa, tethering angle of the anterior leaflet; and Pa, tethering angle of the posterior leaflet. plane, a plane that passes through both commissures and the LV apex. Finally, antero-posterior (AP) plane perpendicular to the center of CC plane was defined for imaging the tented mitral valve (Fig. 1). 11 The sphericity of LV chamber was calculated by the ratio of the LV chamber width measured at the level of the papillary muscle to the height of the level from the mitral annulus using 3D computer software (TomTec, Co., Munich, Germany) during mid-systole. The degree of circularization of the annulus was calculated by the ratio of the AP dimension to the CC dimension of the annulus (Fig. 1). Mitral annular area (MAA) was then calculated with the simplified equation as MAA ¼ 3.14 CC dimension AP dimension/4. The degree of leaflet tethering was estimated by measuring the angle where each leaflet met the annular plane (anterior leaflet: Aa, posterior leaflet: Pa) in AP plane (Fig. 1). Mitral valve tenting area (MVTa), the area enclosed by the annular plane and two leaflets, and mitral valve tenting height (MVTht), the distance between the leaflet coaptation and the mitral annular plane, were also measured in AP plane (Fig. 1). Statistics Data were expressed as mean SD. Group comparisons were analyzed by Student s t test. To determine the predictor of significant MR, multiple logistic regression analysis of 2D and 3D echocardiographic measurements regarding the presence of significant MR as a dependent variable was done. Receiver operator characteristic (ROC) curve analysis was created from the obtained predictor to determine its discrimination (the ability to distinguish between those with and those without significant MR) with the highest sum of sensitivity and specificity. In DorMR group, all 2D and 3D echocardiographic measurements were stratified by ROA and multivariate analysis of these parameters based on stepwise multiple regression analysis was done for the determination of MR severity. A value of P < 0.05 was considered to be significant.

4 198 J. Kwan et al. Results 2D echocardiographic measurements Significant posterior wall motion abnormality was observed in 21 (93%) out of 23 patients with significant MR (DorMR), while it was observed in only 3 (11%) out of 27 patients without significant MR (DorNoMR). In DorMR, ROA of MR was cm 2 (0.21e0.66 cm 2 ). There was no significant difference (P > 0.05) of LV chamber volume between 2 patient groups, but global LV systolic function (EF) was more impaired in DorMR (P < 0.01) (Table 1). 3D echocardiographic measurements Geometric measurements of the mitral valve and annulus including the LV chamber are described in Table 1. Sphericity of the LV chamber at the papillary muscle level increased more (P < 0.01) in DorMR as compared with DorNoMR. MAA and the degree of circularization of the annulus expressed as the ratio of AP dimension to CC dimension of the annulus were significantly larger (P < 0.01) in Table 1 Baseline characteristics and geometric parameters of two patient groups DorNoMR (N ¼ 26) DorMR (N ¼ 22) Age (years) Sex (% male) BSA (m 2 ) LV chamber EDVI (ml/m 2 ) ESVI (ml/m 2 ) EF (%) * Sphericity * Mitral apparatus CC dimension (cm) * AP dimension (cm) * Annular circularization * MAA (cm 2 ) * MVTht (cm) * MVTa (cm 2 ) * Aa ( ) * Pa ( ) * EDVI, end diastolic volume index; ESVI, end systolic volume index; EF, ejection fraction; CC, commissureecommissure; AP, antero-posterior; MAA, mitral annular area; MVTht, mitral valve tenting height; MVTa, mitral valve tenting area; Aa, tethering angle of the anterior leaflet; and Pa, tethering angle of the posterior leaflet. *P < 0.01 vs DorNoMR. DorMR than in DorNoMR. MVTa and MVTht were larger (P < 0.01) in DorMR than in DorNoMR. In DorMR, both Aa and Pa were also larger (P < 0.01) than in DorNoMR. Predictor of significant MR As we explored the major predictor of significant MR in patients with ischemic cardiomyopathy using multiple logistic regression analysis of all geometric measurements regarding the presence of significant MR as a dependent variable, Pa showing prominent difference between two groups (Fig. 2) was found to be the most important geometric predictor of significant MR. Receiver operator characteristic (ROC) curve analysis defined the posterior leaflet angle >47 as the cut-off value discriminating between those with and those without significant MR (moderate MR) with sensitivity of 96% and specificity of 84% (Fig. 3). Determinant of MR severity in patients with significant MR In DorMR, MVTa (r ¼ 0.70, P < 0.001), MAA (r ¼ 0.62, P < 0.001) and Pa (r ¼ 0.49, P ¼ 0.02) showed significant correlation with MR severity (ROA) (Fig. 4) (Table 2). For local LV remodeling, sphericity of LV chamber at the papillary muscle level was significantly associated with ROA (r ¼ 0.50, P ¼ 0.02), whereas neither of the two LV chamber volume indices (EDVI, ESVI) showed significant association with the degree of MR. Multivariate stepwise linear regression analysis of the geometric measurements showing significant correlation with the MR severity defined the MVTa as the strongest determinant of MR severity expressed as ROA (R 2 ¼ 0.49). Pα (º) DorNoMR DorMR Figure 2 Tethering angle of the posterior leaflet (Pa), a main predictor of significant mitral regurgitation in severe ischemic cardiomyopathy.

5 Geometric predictor of ischemic mitral regurgitation 199 scientific approach to appropriate intervention for treating ischemic MR. With the recent advances in 3D imaging techniques, determining the geometric changes of the mitral apparatus that are accompanied by distortion of the regional or global LV chamber have been explored. 3e5,17,18 In these studies, leaflet tethering due to displacement of the papillary muscle has been reported as a main mechanism of functional MR. Figure 3 Receiver operator characteristic (ROC) curve analysis defined the posterior leaflet angle >47 as the cut-off value discriminating between those with and those without significant MR with the highest sum of sensitivity (96%) and specificity (84%). Discussion The presence of significant functional MR that causes pulmonary hypertension 12 and LV volume overload, 13,14 which in turn potentiates the LV remodeling, is a major determinant for the outcome of LV dysfunction, and this is known to be a marker of a poor long-term prognosis in ischemic cardiomyopathy. However, functional MR is a treatable, correctable component of the LV dysfunction. 15 Furthermore, surgical treatment of MR has been suggested to be an important therapeutic option for ischemic cardiomyopathy. 16 Nonetheless, the lack of quantitative data on the geometric determinants of significant MR has hindered the ROA (cm 2 ) r = 0.70 Advantages of RT3DE over 2D echocardiography Of course, the geometric parameters measured in the present study, such as MAA, MVTa and MVTht, can also be provided by 2D echocardiography, as was shown in several previous studies. 19,20 However, considering that the geometric measurement of such small cardiac structures as the annulus or valve requires meticulous care, obtaining the same planes that cross identical portions of the annulus, or that cross at a specific angle (perpendicular to the axis in this study), must be guaranteed in every measurement in order to ensure the reliability of the measurements. Fortunately, the MA has two well-known anatomical reference markers; these are its two commissural points, which are easily delineated in the crosssectional plane of the LV at the valvular level. This requirement for the accurate delineation of the landmarks can be satisfied with using RT3DE and its cropping method in the multi-planar reconstructive modes (TomTec, Co., Munich, Germany). With this method, we obtained the same AP plane vertically crossing the CC plane for the measurement of MVTa, MVTht and the tethering angles of both leaflets in every case. However, this process of measurement is not guaranteed with using conventional 2D echocardiography. ROA (cm 2 ) r = MVTa (cm 2 ) MAA (cm 2 ) Figure 4 Determinants of ROA. Correlations between ROA (y-axis) and, on the x-axis, valvular tenting area (left) and mitral annular area (right). ROA, regurgitant orifice area; MVTa, mitral valve tenting area; and MAA, mitral annular area.

6 200 J. Kwan et al. Table 2 Univariate and multivariate regression analyses for determinants of MR severity (ROA) Univariate Multivariate r P P LV sphericity CC dimension AP dimension MAA MVTht MVTa 0.70 <0.001 <0.001 Pa CC, commissureecommissure; AP, antero-posterior; MAA, mitral annular area; MVTht, mitral valve tenting height; MVTa, mitral valve tenting area; Aa, tethering angle of the anterior leaflet; and Pa, tethering angle of the posterior leaflet. Geometric characteristics of the LV chamber In terms of the LV geometry, our population had several distinctive characteristics as compared to the populations in the previous, similarly designed studies. First, the LV chambers of our patients with significant MR were not enlarged as much as those of the patients in the previous studies. 19,20 Second, there was no significant difference of the LV chamber size between the patients with and without significant MR ( vs ml/m 2, respectively, P > 0.05) in our study, while the LVEDVs of the patients with significant MR were significantly larger than those of the patients without MR in the previous studies. 19,20 Instead, there were two distinctive differences of the LV geometry between the two groups in the present study: posterior wall motion abnormality and LV sphericity. In the present study, the posterior wall motion was severely impaired in most of the patients (93%) with significant MR, while it was preserved in most of the patients (89%) without significant MR. The contribution of the posterior wall motion abnormality to the infarction of the LAD was the reason why the global LV systolic function was more impaired in the DorMR patients. Our finding supported the previous observations that the posterior wall motion abnormality followed by displacement of the posterior-medial papillary muscle and leaflet tethering might be the fundamental mechanism of ischemic MR. 12,21,22 Another contributing mechanism has been suggested by the previous animal studies. 17,22 Glasson et al. 17 have demonstrated that there was enlargement and circularization of the MA after left circumflex artery occlusion, as compared to left anterior descending artery occlusion. This probably resulted from the annular dilatation being confined to the posterior part of the annulus, i.e., the muscular component, which was affected by the posterior wall infarction caused by the LCX occlusion. Of course, ischemic cardiomyopathy with preserved posterior wall motion may cause significant MR. However, this usually occurs in the patients with chronically remodeled LV chamber (LV dilatation) followed by papillary muscle displacement and leaflet tethering, the same as functional MR does in the patients with severe dilated cardiomyopathy. Therefore, posterior wall motion abnormality is probably a fundamental cause of significant MR, particularly for the patients with ischemic cardiomyopathy without severe LV dilatation, as were the cases of our study population. Previous studies have attributed functional MR not to the degree of LV enlargement, but to the degree of LV sphericalization. 12,23,24 In the present study, we had the consistent finding that the LV sphericity, as measured at the papillary muscle level, was significantly increased in the patients with significant MR, and this is probably due to regional (posterior wall) dilatation, compared with the patients without significant MR despite that there was no significant difference in the LV chamber size between them. Geometric characteristic of the mitral apparatus As demonstrated previously, we observed that circular enlargements of the mitral annulus 17,22, leaflet tethering 3,5 and mitral valve tenting 25,26 were more prominent in the patients suffering with significant MR than in the patients without MR. However, among several geometric measurements, significant posterior leaflet tethering (>47 ) was found to be the most important geometric predictor of significant MR in ischemic cardiomyopathy, and this predictor had both high sensitivity and specificity. So then, what is the contribution of annular dilatation to the presence of significant MR? Considering that the valve tolerance to annular dilatation in the normal papillary muscle position was 1.8e2.0 times the norm 23,25e28, a mild to moderate annular enlargement alone might not be enough to produce incomplete leaflet closure for causing significant MR. Therefore, a mild to moderate annular enlargement alone does not seem to play a primary role in generating enough incomplete leaflet closure to cause substantial MR. Instead, it may play an augmentative role along with the other geometric changes such as leaflet

7 Geometric predictor of ischemic mitral regurgitation 201 tethering by the displaced papillary muscles, which has been suggested to be a main cause for ischemic MR. 4 With respect to the geometric determinant of the MR severity in the patients with significant MR, all the measurements except A showed significant correlation (P < 0.05) with the MR severity. Among all the geometric measurements that showed good correlation with the MR severity, the MV tenting area (determined by both the annular dimension and the degree of both the leaflets tethering) was defined as the strongest geometric determinant of the MR severity. This result was consistent with that of a previous clinical study performed on patients with systolic LV dysfunction. 11,25 This finding also suggests that even though generating significant ischemic MR is mainly determined by the degree of leaflet tethering by the displaced papillary muscle rather than by the degree of annular enlargement 29,30, the MR severity is most closely associated with the MV tenting area, as determined by both the degree of annular enlargement and the leaflet tethering. Clinical implications Early surgical repair combined with coronary revascularization should be taken into consideration when treating significant ischemic MR since it yields better patient survival and improved LV function. 31 The present study has proposed the likely geometric predictors with using quantitative data (a tethering angle of the posterior leaflet >47 ) for determining significant MR; this provides for the possibility of a new clinical decision making strategy for the early surgical correction of MR in the patients suffering with ischemic cardiomyopathy. In addition, our result may rationalize and justify the necessity of additive reconstructive surgical intervention to minimize leaflet tethering for the complete correction of MR, besides performing a Dor procedure, if a patient has a large tethering angle of the posterior leaflet before surgery. To meet all these challenges in the clinical setting, RT3DE is an appropriate diagnostic and measurement tool as it provides more precise geometric information on the mitral apparatus than does 2D echocardiography. Study limitations In the present study, we estimated the degree of MR by the PISA method, which was previously validated by a animal study that demonstrated that the degree of MR measured by PISA method was well correlated with that estimated by an electromagnetic flow probe. 32 In this study, all the patients were scheduled for a Dor procedure due to apical aneurysm, so there was a high probability of underestimating the LV sphericity in a conventional way (the ratio of the length from the mitral annular plane to the LV apex to the LV width) 33 because of the lengthened LV chamber via the apical aneurysm. That is the reason why we estimated the LV sphericity at the papillary muscle level. The spatial resolution of the volumetric plane image was limited compared to the conventional 2D images due to the low frequency of the transducer and the parallel processing. However, the mitral annular hinge points and the mitral leaflets have strong signal intensities, which made them easy to identify on the images. Finally, the degree of the papillary muscle displacement was not estimated in the present study. For defining the papillary muscle displacement, the distance from a specific anatomic marker to the head of the papillary muscle should be measured. However, the papillary muscle is anatomically known to be composed of 2 (bifid) or 3 (trifid) separated heads with different distributions of chordae to the MV; this makes it is confusing to determine which head is to be measured. Moreover, although once we determine a specific head to be measured, it would not be easy to discriminate the same head with 100% certainty in every measurement without clear visualization of the chordae distribution. Nevertheless, to better understand the relationship between the mitral valvular geometry and the MR severity, this should be explored in the future in conjunction with the degree of the papillary muscle displacement by using the more advanced RT3DE technique with better resolution. In summary, for the patient suffering from ischemic cardiomyopathy, the LV sphericity, the annular enlargement with circularization and the mitral valve tenting were more prominent in the patients with significant MR than that in those patients without MR. Significant tethering of the posterior leaflet (>47 ) was found to be the important predictor of significant MR, whereas the severity of MR was strongly associated with the MV tenting area. These quantitative geometric data, as determined by RT3DE, may provide a new decision making strategy for performing additional surgical intervention for the correction of MR in the patients suffering with severe ischemic cardiomyopathy. Acknowledgement This study was supported by INHA University Research Grant.

8 202 J. Kwan et al. References 1. Sharma SK, Seckler J, Israel DH, Borrico S, Ambrose JA. Clinical, angiographic and anatomic findings in acute severe ischemic mitral regurgitation. Am J Cardiol 1992;70: 277e Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759e He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 1997;96:1826e Otsuji Y, Handschumacher MD, Liel-Cohen N, Tanabe H, Jiang L, Schwammenthal E, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol 2001;37:641e8. 5. Levine RA, Hung J, Otsuji Y, Messas E, Liel-Cohen N, Nathan N, et al. Mechanistic insights into functional mitral regurgitation. Curr Cardiol Rep 2002;4:125e9. 6. Qin JX, Jones M, Shiota T, Greenberg NL, Tsujino H, Firstenberg MS, et al. Validation of real-time three-dimensional echocardiography for quantifying left ventricular volumes in the presence of a left ventricular aneurysm: in vitro and in vivo studies. J Am Coll Cardiol 2000;36:900e7. 7. Binder TM, Rosenhek R, Porenta G, Maurer G, Baumgartner H. Improved assessment of mitral valve stenosis by volumetric real-time three-dimensional echocardiography. J Am Coll Cardiol 2000;36:1355e Yalcin F, Shiota T, Odabashian J, Agler D, Greenberg NL, Garcia MJ, et al. Comparison by real-time three-dimensional echocardiography of left ventricular geometry in hypertrophic cardiomyopathy versus secondary left ventricular hypertrophy. Am J Cardiol 2000;85:1035e8. 9. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358e Enriquez-Sarano M, Seward JB, Bailey KR, Tajik AJ. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol 1994;23:443e Kwan J, Shiota T, Agler DA, Popovic ZB, Qin JX, Gillinov MA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003;107:1135e Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997;29:153e Junker A, Thayssen P, Nielsen B, Andersen PE. The hemodynamic and prognostic significance of echo-doppler-proven mitral regurgitation in patients with dilated cardiomyopathy. Cardiology 1993;83:14e Evangelista-Masip A, Bruguera-Cortada J, Serrat-Serradell R, Robles-Castro A, Galve-Basilio E, Alijarde-Guimera M, et al. Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69: 373e Rankin JS, Hickey MS, Smith LR, Muhlbaier L, Reves JG, Pryor DB, et al. Ischemic mitral regurgitation. Circulation 1989;79:I116e Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995;109:676e 82 [discussion 682e683]. 17. Glasson JR, Komeda M, Daughters GT, Bolger AF, Karlsson MO, Foppiano LE, et al. Early systolic mitral leaflet loitering during acute ischemic mitral regurgitation. J Thorac Cardiovasc Surg 1998;116:193e Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song JK, Guerrero JL, et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997;96: 1999e Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 2000; 102:1400e Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2003;42:1921e Llaneras MR, Nance ML, Streicher JT, Lima JA, Savino JS, Bogen DK, et al. Large animal model of ischemic mitral regurgitation. Ann Thorac Surg 1994;57:432e Gorman RC, McCaughan JS, Ratcliffe MB, Gupta KB, Streicher JT, Ferrari VA, et al. Pathogenesis of acute ischemic mitral regurgitation in three dimensions. J Thorac Cardiovasc Surg 1995;109:684e Sabbah HN, Kono T, Rosman H, Jafri S, Stein PD, Goldstein S. Left ventricular shape: a factor in the etiology of functional mitral regurgitation in heart failure. Am Heart J 1992;123:961e Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:355e Boltwood CM, Tei C, Wong M, Shah PM. Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation 1983;68:498e Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Stein PD, et al. Mechanism of functional mitral regurgitation during acute myocardial ischemia. J Am Coll Cardiol 1992;19: 1101e Ormiston JA, Shah PM, Tei C, Wong M. Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation 1981;64:113e He S, Lemmon Jr JD, Weston MW, Jensen MO, Levine RA, Yoganathan AP. Mitral valve compensation for annular dilatation: in vitro study into the mechanisms of functional mitral regurgitation with an adjustable annulus model. J Heart Valve Dis 1999;8:294e PerloffJK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation 1972;46:227e Otsuji Y, Kumanohoso T, Yoshifuku S, Matsukida K, Koriyama C, Kisanuki A, et al. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol 2002;39:1651e6.

9 Geometric predictor of ischemic mitral regurgitation Prifti E, Bonacchi M, Frati G, Giunti G, Babatasi G, Sani G. Ischemic mitral valve regurgitation grade IIeIII: correction in patients with impaired left ventricular function undergoing simultaneous coronary revascularization. J Heart Valve Dis 2001;10:754e Shiota T, Jones M, Teien DE, Yamada I, Passafini A, Ge S, et al. Dynamic change in mitral regurgitant orifice area: comparison of color Doppler echocardiographic and electromagnetic flowmeter-based methods in a chronic animal model. J Am Coll Cardiol 1995;26:528e D Cruz IA, Shroff SG, Janicki JS, Jain A, Reddy HK, Lakier JB. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr 1989;2:408e14.

Functional mitral regurgitation (MR), which occurs as a

Functional mitral regurgitation (MR), which occurs as a Geometric Differences of the Mitral Apparatus Between Ischemic and Dilated Cardiomyopathy With Significant Mitral Regurgitation Real-Time Three-Dimensional Echocardiography Study Jun Kwan, MD; Takahiro

More information

Determinants of Exercise-Induced Changes in Mitral Regurgitation in Patients With Coronary Artery Disease and Left Ventricular Dysfunction

Determinants of Exercise-Induced Changes in Mitral Regurgitation in Patients With Coronary Artery Disease and Left Ventricular Dysfunction Journal of the American College of Cardiology Vol. 42, No. 11, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.04.002

More information

Quantitation of Mitral Valve Tenting in Ischemic Mitral Regurgitation by Transthoracic Real-Time Three-Dimensional Echocardiography

Quantitation of Mitral Valve Tenting in Ischemic Mitral Regurgitation by Transthoracic Real-Time Three-Dimensional Echocardiography Journal of the American College of Cardiology Vol. 45, No. 5, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.048

More information

Methods Population. Echocardiographic assessment

Methods Population. Echocardiographic assessment Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy: Data from the Acorn trial Seong-Mi Park, MD, a Seung Woo Park, MD,

More information

ACD. Surgery for Acquired Cardiovascular Disease. The Journal of Thoracic and Cardiovascular Surgery Volume 125, Number 1 135

ACD. Surgery for Acquired Cardiovascular Disease. The Journal of Thoracic and Cardiovascular Surgery Volume 125, Number 1 135 Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction: Quantitative analysis of left ventricular and mitral valve geometry in 103 patients with

More information

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Case Report Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System Antonio Chiricolo 1*, Leonard Y Lee 2 1 Department of Anesthesiology, Rutgers

More information

How to assess ischaemic MR?

How to assess ischaemic MR? ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège ESC 2012 No conflict of interest Luc

More information

Ischaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic

Ischaemic mitral regurgitation is a distinctive valve disease in that, unlike with organic Correspondence to: Professor Bernard Iung, Service de Cardiologie, Groupe Hospitalier Bichat-Claude Bernard, 46, rue Henri-Huchard, 75877 Paris Cedex 18, France; bernard.iung@ bch.ap-hop-paris.fr Valve

More information

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:

More information

The New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography

The New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography Clinical Practice This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines,

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema

The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema The new england journal of medicine original article The Role of Ischemic Mitral Regurgitation in the Pathogenesis of Acute Pulmonary Edema Luc A. Piérard, M.D., Ph.D., and Patrizio Lancellotti, M.D. abstract

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/20135 holds various files of this Leiden University dissertation. Author: Braun, Jerry Title: Surgical treatment of functional mitral regurgitation Issue

More information

What echo measurements are key prior to MitraClip?

What echo measurements are key prior to MitraClip? APHP CHU Bichat - Claude Bernard What echo measurements are key prior to MitraClip? Eric Brochet,MD Cardiology Department Hopital Bichat Paris France No disclosure Conflict of interest Case 69 y.o man

More information

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II SURGICAL RISK IN VALVULAR HEART DISEASE: WHAT 2D AND 3D ECHO CAN TELL YOU AND WHAT THEY CAN'T Ernesto E Salcedo, MD Professor of Medicine University of Colorado School of Medicine Director of Echocardiography

More information

Primary Mitral Regurgitation

Primary Mitral Regurgitation EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,

More information

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application Part II: Fundamentals of 3D Echocardiography: Acquisition and Application Dr. Bruce Bollen 3D matrix array TEE probes provide options for both 2D and 3D imaging. Indeed, their utility in obtaining multiple

More information

Chronic Ischemic Mitral Regurgitation

Chronic Ischemic Mitral Regurgitation Author: Please check highlighted matter in text. CHRONIC ISCHEMIC LV SYSTOLIC DYSFUNCTION Chronic Ischemic Mitral Regurgitation 16 CHAPTER Raluca Dulgheru, Patrizio Lancellotti INTRODUCTION Secondary Mitral

More information

Influence of Chronic Tethering of the Mitral Valve on Mitral Leaflet Size and Coaptation in Functional Mitral Regurgitation

Influence of Chronic Tethering of the Mitral Valve on Mitral Leaflet Size and Coaptation in Functional Mitral Regurgitation JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 4, BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. DOI:./j.jcmg.11..004 ORIGINAL RESEARCH Influence of Chronic

More information

Martin G. Keane, MD, FASE Temple University School of Medicine

Martin G. Keane, MD, FASE Temple University School of Medicine Martin G. Keane, MD, FASE Temple University School of Medicine Measurement of end-diastolic LV internal diameter (LVIDd) made by properly-oriented M-Mode techniques in the Parasternal Long Axis View (PLAX):

More information

When Does 3D Echo Make A Difference?

When Does 3D Echo Make A Difference? When Does 3D Echo Make A Difference? Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network 1 Practical Applications of 3D Echocardiography Recommended

More information

Functional Mitral Regurgitation

Functional Mitral Regurgitation Club 35 - The best in heart valve disease - Functional Mitral Regurgitation Steven Droogmans, MD, PhD UZ Brussel, Jette, Belgium 08-12-2011 Euroecho & other Imaging Modalities 2011 No conflicts of interest

More information

Revealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane

Revealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane Ultrasound cardiology irotate and xplane Revealing new insights irotate electronic rotation and xplane adjustable biplane imaging Annemien van den Bosch and Jackie McGhie Department of Cardiology, Erasmus

More information

Mechanistic Insights Into Posterior Mitral Leaflet Inter-Scallop Malcoaptation During Acute Ischemic Mitral Regurgitation

Mechanistic Insights Into Posterior Mitral Leaflet Inter-Scallop Malcoaptation During Acute Ischemic Mitral Regurgitation Mechanistic Insights Into Posterior Mitral Leaflet Inter-Scallop Malcoaptation During Acute Ischemic Mitral Regurgitation David T. Lai, FRACS; Frederick A. Tibayan, MD; Truls Myrmel, MD; Tomasz A. Timek,

More information

Acute Effects of Cardiac Resynchronization Therapy on Functional Mitral Regurgitation in Advanced Systolic Heart Failure

Acute Effects of Cardiac Resynchronization Therapy on Functional Mitral Regurgitation in Advanced Systolic Heart Failure Journal of the American College of Cardiology Vol. 41, No. 5, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02937-6

More information

MITRAL REGURGITATION ECHO PARAMETERS TOOL

MITRAL REGURGITATION ECHO PARAMETERS TOOL Comprehensive assessment of qualitative and quantitative parameters, along with the use of standardized nomenclature when reporting echocardiographic findings, helps to better define a patient s MR and

More information

Left atrial function. Aliakbar Arvandi MD

Left atrial function. Aliakbar Arvandi MD In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial

More information

Chamber Quantitation Guidelines: What is New?

Chamber Quantitation Guidelines: What is New? Chamber Quantitation Guidelines: What is New? Roberto M Lang, MD J AM Soc Echocardiogr 2005; 18:1440-1463 1 Approximately 10,000 citations iase in itune Cardiac Chamber Quantification: What is New? Database

More information

Mitral tetrahedron as a geometrical surrogate for chronic ischemic mitral regurgitation

Mitral tetrahedron as a geometrical surrogate for chronic ischemic mitral regurgitation Am J Physiol Heart Circ Physiol 289: H1218 H1225, 2005. First published April 29, 2005; doi:10.1152/ajpheart.00169.2005. Mitral tetrahedron as a geometrical surrogate for chronic ischemic mitral regurgitation

More information

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 Imaging MV Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 MV/MR: information needed on.. 1. MV anatomy 2. MR etiology - primary vs secondary 3. MR severity quantification

More information

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Valvular Regurgitation: Can We Do Better Than Colour Doppler? Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology Valvular Regurgitation Valve regurgitation volume loads the ventricles

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Regurgitant Lesions Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Aortic Insufficiency Valve anatomy and function LVOT and

More information

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD 3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD Asan Medical Center University of Ulsan College of Medicine Seoul, Korea Causes of TR Primary causes (25%) Rheumatic Myxomatous

More information

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial

More information

A New Method to Rapidly Evaluate LVEF from a Contractility Polar Map. Lebeau et al.

A New Method to Rapidly Evaluate LVEF from a Contractility Polar Map. Lebeau et al. A New Method to Rapidly Evaluate LVEF from a Contractility Polar Map Lebeau et al. Good afternoon It is my pleasure to present to you a new method to rapidly evaluate LVEF from a contractility polar map

More information

Ischemic Mitral Regurgitation: A Quantitative Three-Dimensional Echocardiographic Analysis

Ischemic Mitral Regurgitation: A Quantitative Three-Dimensional Echocardiographic Analysis Ischemic Mitral Regurgitation: A Quantitative Three-Dimensional Echocardiographic Analysis Mathieu Vergnat, MD, Arminder S. Jassar, MBBS, Benjamin M. Jackson, MD, Liam P. Ryan, MD, Thomas J. Eperjesi,

More information

MAYON VOLCANO: FAST FACTS

MAYON VOLCANO: FAST FACTS MAYON VOLCANO: FAST FACTS Type of Volcano: Stratovolcano Elevation: 2.46 km Base Diameter: 20 km Base Circumference: 62.8 km Area: 314.1 km 2 Reference: http://www.phivolcs.dost.gov.ph/html/update_vmepd/volcano/volcanolist/mayon.htm

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

Conflict of Interests

Conflict of Interests The Left Ventricle: How Should We Quantify Its Size and Function; Is It Time for 3D in Everyone? Roberto M Lang, MD Conflict of Interests Philips Medical Imaging Research Grants Speakers bureau Advisory

More information

Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False?

Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False? Mechanisms of False Positive Exercise Electrocardiography: Is False Positive Test Truly False? Masaki Izumo a, Kengo Suzuki b, Hidekazu Kikuchi b, Seisyo Kou b, Keisuke Kida b, Yu Eguchi b, Nobuyuki Azuma

More information

Mitral regurgitation (MR) is a common and morbid condition. Original Article

Mitral regurgitation (MR) is a common and morbid condition. Original Article Original Article Assessment of Mitral Valve Adaptation With Gated Cardiac Computed Tomography Validation With Three-Dimensional Echocardiography and Mechanistic Insight to Functional Mitral Regurgitation

More information

Mitral Valve Tenting Index for Assessment of Subvalvular Remodeling

Mitral Valve Tenting Index for Assessment of Subvalvular Remodeling Mitral Valve Tenting Index for Assessment of Subvalvular Remodeling Liam P. Ryan, MD, Benjamin M. Jackson, MD, Landi M. Parish, SB, Hiroaki Sakamoto, MD, Theodore J. Plappert, CVT, Martin St. John-Sutton,

More information

Quantification of Cardiac Chamber Size

Quantification of Cardiac Chamber Size 2017 KSE 2017-11-25 Quantification of Cardiac Chamber Size Division of Cardiology Keimyung University Dongsan Medical Center In-Cheol Kim M.D., Ph.D. LV size and function Internal linear dimensions PLX

More information

Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function

Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function Global left ventricular circumferential strain is a marker for both systolic and diastolic myocardial function Toshinari Onishi 1, Samir K. Saha 2, Daniel Ludwig 1, Erik B. Schelbert 1, David Schwartzman

More information

2/2/2011. Strain and Strain Rate Imaging How, Why and When? Movement vs Deformation. Doppler Myocardial Velocities. Movement. Deformation.

2/2/2011. Strain and Strain Rate Imaging How, Why and When? Movement vs Deformation. Doppler Myocardial Velocities. Movement. Deformation. Strain and Strain Rate Imaging How, Why and When? João L. Cavalcante, MD Advanced Cardiac Imaging Fellow Cleveland Clinic Foundation Disclosures: No conflicts of interest Movement vs Deformation Movement

More information

Chapter 20. JACC Cardiovasc Imaging 2009;2:

Chapter 20. JACC Cardiovasc Imaging 2009;2: Chapter 20 Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance N Ajmone Marsan, J JM Westenberg, C Ypenburg,

More information

pissn: , eissn: Yonsei Med J 55(3): , 2014

pissn: , eissn: Yonsei Med J 55(3): , 2014 Original Article http://dx.doi.org/1.3349/ymj.214.55.3.592 pissn: 513-5796, eissn: 1976-2437 Yonsei Med J 55(3):592-598, 214 Response of Functional Mitral Regurgitation during Dobutamine Infusion in Relation

More information

REVIEW J Cardiovasc Ultrasound 2008;16(1):1-8. KEY WORDS: Mitral regurgitation Ischemia Papillary muscle Tethering.

REVIEW J Cardiovasc Ultrasound 2008;16(1):1-8. KEY WORDS: Mitral regurgitation Ischemia Papillary muscle Tethering. ISSN 1975-4612 c 2008, Korean Society of Echocardiography www.kse-jcu.org REVIEW J Cardiovasc Ultrasound 2008;16(1):1-8 Mechanism of Ischemic Mitral Regurgitation Yutaka Otsuji, MD 1, Robert A. Levine,

More information

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Valve Analysis and Pathoanatomy: THE MITRAL VALVE : THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery

More information

When should we intervene surgically in pediatric patient with MR?

When should we intervene surgically in pediatric patient with MR? When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH

More information

Cardiac ultrasound protocols

Cardiac ultrasound protocols Cardiac ultrasound protocols IDEXX Telemedicine Consultants Two-dimensional and M-mode imaging planes Right parasternal long axis four chamber Obtained from the right side Displays the relative proportions

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

Patterns of Left Ventricular Remodeling in Chronic Heart Failure: The Role of Inadequate Ventricular Hypertrophy

Patterns of Left Ventricular Remodeling in Chronic Heart Failure: The Role of Inadequate Ventricular Hypertrophy Abstract ESC 82445 Patterns of Left Ventricular Remodeling in Chronic Heart Failure: The Role of Inadequate Ventricular Hypertrophy FL. Dini 1, P. Capozza 1, P. Fontanive 2, MG. Delle Donne 1, V. Santonato

More information

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload

More information

Echocardiographic Assessment of the Left Ventricle

Echocardiographic Assessment of the Left Ventricle Echocardiographic Assessment of the Left Ventricle Theodora Zaglavara, MD, PhD, BSCI/BSCCT Department of Cardiovascular Imaging INTERBALKAN EUROPEAN MEDICAL CENTER 2015 The quantification of cardiac chamber

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography Ertunc Altiok, Sandra Hamada, Silke van Hall, Mehtap Hanenberg, Eva Grabskaya, Michael Becker,

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:

More information

Journal of the American College of Cardiology Vol. 61, No. 17, by the American College of Cardiology Foundation ISSN /$36.

Journal of the American College of Cardiology Vol. 61, No. 17, by the American College of Cardiology Foundation ISSN /$36. Journal of the American College of Cardiology Vol. 61, No. 17, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.064

More information

Role of real-time three-dimensional transesophageal echocardiography in mitral valve repair

Role of real-time three-dimensional transesophageal echocardiography in mitral valve repair Journal of Geriatric Cardiology September 2008 Vol 5 No 3 137 Clinical Research Role of real-time three-dimensional transesophageal echocardiography in mitral valve repair Cuizhen Pan 1, Xianhong Shu 1,

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

The Key Questions in Mitral Valve Interventions. Where Are We in 2018? The Key Questions in Mitral Valve Interventions Where Are We in 2018? Gilles D. DREYFUS, MD, FRCS, FESC Professor of Cardiothoracic Surgery 30 GIORNATE CARDIOLOGICHE TORINESI - OCT 2018 Are guidelines

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Tissue Doppler Imaging in Congenital Heart Disease

Tissue Doppler Imaging in Congenital Heart Disease Tissue Doppler Imaging in Congenital Heart Disease L. Youngmin Eun, M.D. Department of Pediatrics, Division of Pediatric Cardiology, Kwandong University College of Medicine The potential advantage of ultrasound

More information

Normal TTE/TEE Examinations

Normal TTE/TEE Examinations Normal TTE/TEE Examinations Geoffrey A. Rose, MD FACC FASE Sanger Heart & Vascular Institute Before you begin imaging... Obtain the patient s Height Weight BP PLAX View PLAX View Is apex @ 9-10 o clock?

More information

Echocardiographic Evaluation of Primary Mitral Regurgitation

Echocardiographic Evaluation of Primary Mitral Regurgitation Echocardiographic Evaluation of Primary Mitral Regurgitation Roberto M Lang, MD 0-10 o ME 4CH Med A2 P2 50-70 o Commissural P3 P1 A2 80-100 o ME 2CH P3 A2 A1 A1 125-135 o - ME Long axis P2 A2 P3 A3 P2

More information

Update on Mitral Repair in Dilated Cardiomyopathy

Update on Mitral Repair in Dilated Cardiomyopathy 396 Update on Mitral Repair in Dilated Cardiomyopathy Matthew A. Romano, M.D., and Steven F. Bolling, M.D. University of Michigan, Section of Cardiac Surgery, Ann Arbor, Michigan ABSTRACT Heart failure

More information

The echocardiographic assessment of functional mitral regurgitation

The echocardiographic assessment of functional mitral regurgitation European Journal of Echocardiography (2010) 11, i11 i17 doi:10.1093/ejechocard/jeq121 REVIEW The echocardiographic assessment of functional mitral regurgitation Simon Ray* University Hospitals of South

More information

Segmental Tissue Doppler Image-Derived Tei Index in Patients With Regional Wall Motion Abnormalities

Segmental Tissue Doppler Image-Derived Tei Index in Patients With Regional Wall Motion Abnormalities ORIGINAL ARTICLE DOI 10.4070 / kcj.2010.40.3.114 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright c 2010 The Korean Society of Cardiology Open Access Segmental Tissue Doppler Image-Derived Tei Index

More information

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines - Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary

Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary 1 IMAGES IN CARDIOVASCULAR ULTRASOUND 2 3 4 Multimodality Imaging of Anomalous Left Coronary Artery from the Pulmonary Artery 5 6 7 Byung Gyu Kim, MD 1, Sung Woo Cho, MD 1, Dae Hyun Hwang, MD 2 and Jong

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension ESC Congress 2011.No 85975 Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension Second Department of Internal

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/20135 holds various files of this Leiden University dissertation. Author: Braun, Jerry Title: Surgical treatment of functional mitral regurgitation Issue

More information

Certificate in Clinician Performed Ultrasound (CCPU) Syllabus. Rapid Cardiac Echo (RCE)

Certificate in Clinician Performed Ultrasound (CCPU) Syllabus. Rapid Cardiac Echo (RCE) Certificate in Clinician Performed Ultrasound (CCPU) Syllabus Rapid Cardiac Echo (RCE) Purpose: Rapid Cardiac Echocardiography (RCE) This unit is designed to cover the theoretical and practical curriculum

More information

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction October 4, 2014 James S. Lee, M.D., F.A.C.C. Associates in Cardiology, P.A. Silver Spring, M.D. Disclosures Financial none

More information

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA New 3D Quantification of Mitral Regurgitation Severity Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA No Financial Disclosures No off label discussion of devices

More information

Assessing the Impact on the Right Ventricle

Assessing the Impact on the Right Ventricle Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal

More information

Myocardial performance index, Tissue Doppler echocardiography

Myocardial performance index, Tissue Doppler echocardiography Value of Measuring Myocardial Performance Index by Tissue Doppler Echocardiography in Normal and Diseased Heart Tarkan TEKTEN, 1 MD, Alper O. ONBASILI, 1 MD, Ceyhun CEYHAN, 1 MD, Selim ÜNAL, 1 MD, and

More information

THE LEFT ATRIUM HOW CAN ECHO HELP US?

THE LEFT ATRIUM HOW CAN ECHO HELP US? THE LEFT ATRIUM HOW CAN ECHO HELP US? Dr. Dragos COZMA BACKGROUND Left atrium (LA) dilation can occur in a broad spectrum of cardiovascular diseases including hypertension, left ventricular dysfunction,

More information

Echocardiographic visualization of the anatomic causes of mitral regurgitation

Echocardiographic visualization of the anatomic causes of mitral regurgitation Postgraduate Medical Journal (May 1982) 58, 257-263 PAPERS Echocardiographic visualization of the anatomic causes of mitral regurgitation resulting from myocardial infarction ROBERT M. DONALDSON M.R.C.P.

More information

Characteristics of Left Ventricular Diastolic Function in Patients with Systolic Heart Failure: A Doppler Tissue Imaging Study

Characteristics of Left Ventricular Diastolic Function in Patients with Systolic Heart Failure: A Doppler Tissue Imaging Study Characteristics of Left Ventricular Diastolic Function in Patients with Systolic Heart Failure: A Doppler Tissue Imaging Study Bassem A. Samad, MD, PhD, Jens M. Olson, MD, and Mahbubul Alam, MD, PhD, FESC,

More information

Strain and Strain Rate Imaging How, Why and When?

Strain and Strain Rate Imaging How, Why and When? Strain and Strain Rate Imaging How, Why and When? João L. Cavalcante, MD Advanced Cardiac Imaging Fellow Cleveland Clinic Foundation Disclosures: No conflicts of interest Movement vs Deformation Movement

More information

Assessment of cardiac function with 3D echocardiography. Đánh giá chức năng tim bằng siêu âm tim 3D

Assessment of cardiac function with 3D echocardiography. Đánh giá chức năng tim bằng siêu âm tim 3D Assessment of cardiac function with 3D echocardiography Đánh giá chức năng tim bằng siêu âm tim 3D TS. BS. Nguyễn Thị Thu Hoài Viện Tim Mạch Quốc Gia Việt Nam TỪ SIÊU ÂM M-mode ĐẾN SIÊU ÂM 3D TỪ SIÊU ÂM

More information

ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP

ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP ΒΛΑΣΗΣ ΝΙΝΙΟΣ MD MRCP ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ ΘΕΣΣΑΛΟΝΙΚΗ CONFLICT OF INTEREST PROCTOR

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

Age and body surface area dependency of mitral valve and papillary apparatus parameters: assessment by real-time three-dimensional echocardiography

Age and body surface area dependency of mitral valve and papillary apparatus parameters: assessment by real-time three-dimensional echocardiography European Journal of Echocardiography (2009) 10, 287 294 doi:10.1093/ejechocard/jen237 Age and body surface area dependency of mitral valve and papillary apparatus parameters: assessment by real-time three-dimensional

More information

Mitral valve repair in ischemic mitral regurgitation

Mitral valve repair in ischemic mitral regurgitation doi:10.1510/mmcts.2004.000521 Mitral valve repair in ischemic mitral regurgitation Antonio Maria Calafiore a, *, Michele Di Mauro b, Marco Contini b, Luca Weltert a, Antonio Bivona b a Division of Cardiac

More information

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8

More information

좌심실수축기능평가 Cardiac Function

좌심실수축기능평가 Cardiac Function Basic Echo Review Course 좌심실수축기능평가 Cardiac Function Seonghoon Choi Cardiology Hallym university LV systolic function Systolic function 좌심실수축기능 - 심근의수축으로심실에서혈액을대동맥으로박출하는기능 실제임상에서 LV function 의의미 1Diagnosis

More information

Three-dimensional echocardiography in the clinical world

Three-dimensional echocardiography in the clinical world Three-dimensional echocardiography in the clinical world Dr. JL Zamorano Director CV Institute University Clinic SC, Madrid Advantages of 3D. Spatial manipulation. Optimal alineation of structures. Views

More information

What are the best diagnostic tools to quantify aortic regurgitation?

What are the best diagnostic tools to quantify aortic regurgitation? What are the best diagnostic tools to quantify aortic regurgitation? Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique Université catholique de Louvain

More information

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin

More information